“Our vaccine will be used as a 4th dose”
Moderna has been ahead of its competitors by announcing, just a few days ago, the good results of its updated vaccine against Ómicron, ARNm-1273.214. According to early clinical data, increases up to eight times the neutralizing antibodies against Beta, Delta and Omicron, with a safety and tolerability profile consistent with its original booster dose. Dan … Read more